This could lead to increased energy expenditure and a greater utilization of fat stores for fuel, thereby facilitating fat loss over time
Wegovy is now the first weight-loss medication to also be approved to help prevent life-threatening cardiovascular events in adults with cardiovascular disease and either obesity or overweight, says John Sharretts, MD, director of the division of diabetes, lipid disorders, and obesity in the FDAs Center for Drug Evaluation and Research, in a release
Longevity Pro Panel Advanced biomarker insights to help you optimize metabolism, hormones, inflammation, and biological agingguided by experts in longevity science
Regulators said many of the companies were promoting compounded medications as if they were equivalent to approved brand-name drugs
In addition to affecting blood sugar and insulin levels, studies have shown these injections are excellent at promoting weight loss